Table 1 Baseline information of included studies for glioma diagnosis
Reference | Year | Country | Design | Specimens No. | Patients No. | Age, yr | M/F | Test | Prior treatment | Occurrence | Gold Standard | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Meana | Median | |||||||||||
Chen et al. [9] | 2006 | US | Prospective | 27 | 30 (27b) | – | – | – | PET | With or without | 7 New+ 20 Recur | Histo+Radio+follow-up |
Tripathi et al. [10] | 2009 | India | Prospective | 15 | 15 | 28.4 ± 11.1 | – | 9/6 | PET/CT | With (Sx/CT/RT) or without | 3 New+ 12 Recur | Histo+Radio+follow-up |
Sellam et al. [22] | 2010 | India | Prospective | 30 | 30 | – | – | – | PET/CT | Sx+/−RT | Recur | Histo+Radio+follow-up |
Jora et al. [23] | 2011 | India | Prospective | 23 | 23 | 43.25 ± 14.9 | – | – | PET/CT | 15 with (Sx + RT) + 8 without | 8 New+ 15 Recur | Histo+Radio+follow-up |
Karunanithi et al. [15] | 2013 | India | Prospective | 35 | 35 | 36.62 ± 0.86 | – | 28/7 | PET/CT | Sx + RT+/−CT | Recur | Histo+Radio+follow-up |
Pafundi et al. [24] | 2013 | US | Prospective | 23 | 10 | 40.8 ± 18.9 | – | 9/1 | PET/CT | With or without | 8 New+ 2 Recur | Histo |
Herrmann et al. [25] | 2014 | US | Retrospective | 110 | 110 | 51.7 ± 12.1 | 52.5 | 72/38 | PET/CT | Sx | Recur | Histo+Radio+follow-up |
Moran et al. [26] | 2015 | Italy | Retrospective | 27 | 27 | 10 | 10 | 15/12 | PET | 1 with (Sx + CT + RT) + 20 without | 20 New+ 1 Recur | Histo+Radio+follow-up |
Sharma et al. [27] | 2016 | India | Prospective | 12 | 11 | 34 | – | 6/5 | PET/CT | Sx | Recur | Histo+Radio+follow-up |
Paquet et al. [28] | 2017 | France | Prospective | 60 | 35 | 60 | – | – | PET | Sx + CT + RT | Recur | Histo+Radio |
Evangelista et al. [29] | 2018 | Italy | Retrospective | 13 | 13 | – | 60 | – | PET/CT | Unclear | Recur | Radio+follow-up |
Youland et al. [30] | 2018 | US | Prospective | 37 | 13 | – | 40 | 9/4 | PET | Sx/CT/RT | Recur | Histo |
Evangelista et al. [31] | 2019 | Italy | Retrospective | 21 | 21 | 58 ± 11 | – | – | PET/CT | Sx + CT/RT/immunotherapy | Recur | Radio+follow-up |